Prévia documental · candidata sem aceite clínico humano
14. Referências
1. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care [Internet]. 2025 Jan 1;48(Supplement_1):S27–49. Link · Resumo no PubMed
2. Rodacki M, Cobas RA, Zajdenverg L, Silva Júnior WS da, Giacaglia L, Calliari LE, et al. Diagnóstico de diabetes mellitus. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
3. Diabetes do tipo 2 em adultos Direto ao local de atendimento. 2025.
4. BMJ. Diabetes do tipo 2 em adultos. Direto ao local do atendimento. BMJ Best Practice. 2024;
5. WORLD HEALTH ORGANIZATION. Prevalence of diabetes (age-standardized). Geneva: WHO, [2025?]. Link
6. WHO - World Health Organization. Diabetes [Internet]. WHO - World Health Organization. 2024 [cited 2025 Aug 31]. Link
7. International Diabetes Federation (IDF). Diabetes country report 2000 — 2050. Brazil. [Internet]. International Diabetes Federation (IDF). 2025 [cited 2025 Nov 23]. Link
8. Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Vol. 34, Cell Metabolism. Cell Press; 2022. p. 11–20. Link · Resumo no PubMed
9. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice. 2022 Oct;28(10):923–1049. Link · Resumo no PubMed
10. International Diabetes Federation (IDF). IDF Diabetes Atlas 11th Edition Committee [Internet]. 2025 [cited 2025 Sep 15]. Link
11. BRASIL. Presidência da República. Casa Civil. Lei no 8.080, de 19 de setembro de 1990. Dispõe sobre as condições para a promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras providências e dá outras providências. [Internet]. Presidência da República. Casa Civil. . 1990 [cited 2025 Sep 15]. Link
12. Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab [Internet]. 2016;20(4). Link · Resumo no PubMed
13. Tschiedel B. Complicações crônicas do diabetes. J Bras Med. 2014;102(5):1–7. Link
14. Seid MA, Akalu Y, Gela YY, Belsti Y, Diress M, Fekadu SA, et al. Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia. Diabetol Metab Syndr [Internet]. 2021;13(1):86. Link · Resumo no PubMed
15. Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomedicine & Pharmacotherapy [Internet]. 2020;131:110708. Link · Resumo no PubMed
16. Brasil. Ministério da Saúde. Portaria No 62 de 6 de janeiro de 2017. 2017; Link
17. Brasil. Ministério da Saúde. Portaria de consolidação no 3, de 28 de setembro de 2017. 2017; Link
18. Bardenheier BH, Wu WC, Zullo AR, Gravenstein S, Gregg EW. Progression to diabetes by baseline glycemic status among middle-aged and older adults in the United States, 2006–2014. Diabetes Res Clin Pract. 2021 Apr 1;174. Link · Resumo no PubMed
19. Brasil. Linha de cuidado - Diabetes Mellitus tipo 2 (DM2) no adulto (Primeira Versão) [Internet]. Ministério da Saúde . 2023 [cited 2025 May 13]. Link
20. Barim EM, McLellan KCP, Ribeiro RS, Carvalho JAM de, Lindström J, Tuomilehto J, et al. Translation and cultural adaptation into Brazilian Portuguese of the Finnish Diabetes Risk Score (FINDRISC) and reliability assessment. Revista Brasileira de Epidemiologia. 2020;23. Link · Resumo no PubMed
21. Brasil. Ministério da Saúde. Linha de Cuidado do Adulto com Diabetes Mellitus tipo 2 (DM2) [Internet]. Brasília; 2020 [cited 2024 Jul 30]. Link
22. Type 2 diabetes: prevention in people at high risk [Internet]. 2012. Link
23. SBD. Diretriz da Sociedade Brasileira de Diabetes - Edição 2023. . Link
24. ADA. American Diabetes Association Standards of Care in Diabetes. Link
25. USPSTF. Prediabetes and Type 2 Diabetes: Screening. Link
26. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S27–49. Link · Resumo no PubMed
27. Brasil. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas Diabete Melito tipo 2 [Internet]. Brasília; 2024 Feb [cited 2024 Jul 30]. Link
28. Duncan BB, Schmidt MI,, Giugliani ER. Medicina ambulatorial: Condutas de atenção primária baseadas em evidências. Artmed; 2022. Link
29. WHO. World Health Organization. HEARTS D: diagnosis and management of type 2 diabetes. Geneva; 2020. Link
30. Rodacki M, Teles M, Gabbay M, Montenegro R, Bertoluci M. Classificação do diabetes. In: Diretriz Oficial da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2022. Link
31. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S27–49. Link · Resumo no PubMed
32. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 14. Children and Adolescents: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S283–305. Link · Resumo no PubMed
33. Quattrocchi E, Goldberg T, Marzella N. Management of type 2 diabetes: consensus of diabetes organizations. Drugs Context. 2020 Jan 27;9:1–25. Link · Resumo no PubMed
34. Bertoluci MC, Silva Júnior WS, Valente F, Araujo LR, Lyra R, de Castro JJ, et al. 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes. Diabetol Metab Syndr. 2023 Jul 19;15(1):160. Link · Resumo no PubMed
35. Rodacki M, Cobas RA, Zajdenverg L, Silva Júnior WS da, Giacaglia L, Calliari LE, et al. Diagnóstico de diabetes mellitus. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
36. OPAS. Calculadora de risco cardiovascular - HEARTS. [Internet]. Organização Mundial de Saúde. [cited 2025 May 13]. Link
37. de Souza Brito TN, De Araújo-Oliveira AR,, Da Silva AKC. Taxa de filtração glomerular estimada em adultos: características e limitações das equações utilizadas. RBAC. 2016;48(1):7–12. Link
38. Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2011). 2013 Jan;3(1):1. Link
39. Brasil. Protocolo Clínico e Diretrizes Terapêuticas de Diabete Melito Tipo 2. Brasília; 2024. Link
40. BMJ. BMJ Best Practice: DM tipo 2 em adultos. BMJ Best Practice [Internet]. 2022 [cited 2025 May 13]; Link
41. Brasil. Estratégia de Saúde Cardiovascular na Atenção Primária à Saúde: instrutivo para profissionais e gestores. Brasília; 2022. Link
42. Pedroso Camargos A, Barreto S, Brant L, Ribeiro ALP, Dhingra LS, Aminorroaya A, et al. Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study. Open Heart. 2024 Jun 11;11(1):e002762. Link · Resumo no PubMed
43. Précoma DB, Oliveira GMM de, Simão AF, Dutra OP, Coelho-Filho OR, Izar MC de O, et al. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019. Arq Bras Cardiol. 2019; Link · Registro no PubMed
44. Brasil. Protocolo Clínico e Diretrizes Terapêuticas da Dislipidemia: prevenção eventos cardiovasculares e pancreatite. [Internet]. Brasília; 2019 [cited 2025 May 14]. Link
45. Quattrocchi E, Goldberg T, Marzella N. Management of type 2 diabetes: consensus of diabetes organizations. Drugs Context. 2020;9. Link · Resumo no PubMed
46. Brasil. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas de Sobrepeso e Obesidade em Adultos. Link
47. NICE. Type 2 diabetes in adults: management. NICE guideline - NG28 [Internet]. 2022 [cited 2025 May 13]. Link
48. Pititto B, Dias M, Moura F, Lamounier R, Calliari S, Bertoluci M. Metas no tratamento do diabetes. Diretriz Oficial da Sociedade Brasileira de Diabetes. 2022. Link
49. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine. 1993 Sep 30;329(14):977–86. Link · Resumo no PubMed
50. The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine. 2008 Jun 12;358(24):2560–72. Link · Resumo no PubMed
51. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998 Sep;352(9131):854–65. Link · Resumo no PubMed
52. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 Aug 12;321(7258):405–12. Link · Resumo no PubMed
53. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. The Lancet. 2010 Feb;375(9713):481–9. Link · Resumo no PubMed
54. Brasil. Ministério da Saúde. Linha de cuidado - DM2. Link
55. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S86– 127. Link · Resumo no PubMed
56. Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2019- 2020 . São Paulo; 2019. Link
57. Ramos S, Campos LF, Baptista DR, Strufaldi M, Gomes DL, Guimarães DB, et al. Terapia Nutricional no Pré-Diabetes e no Diabetes Mellitus Tipo 2. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2023. Link
58. WHO. World Health Organization. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. 2003. Link · Resumo no PubMed
59. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998 Sep;352(9131):854–65. Link · Resumo no PubMed
60. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow- up of the Finnish Diabetes Prevention Study. The Lancet. 2006 Nov;368(9548):1673–9. Link · Resumo no PubMed
61. Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care. 2019 May 1;42(5):731–54. Link · Registro no PubMed
62. Aas AM, Axelsen M, Churuangsuk C, Hermansen K, Kendall CWC, Kahleova H, et al. Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023 Jun 17;66(6):965–85. Link · Resumo no PubMed
63. Raveendran A, Chacko EC, Pappachan JM. Non-pharmacological Treatment Options in the Management of Diabetes Mellitus. Eur Endocrinol. 2018;14(2):31. Link · Resumo no PubMed
64. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022 Nov 1;45(11):2753–86. Link · Resumo no PubMed
65. Brasil. Cadernos de Atenção Básica - Estratégias para o cuidado da pessoa com doença crônica: diabetes mellitus [Internet]. Brasília; 2013 [cited 2025 May 13]. Link
66. Brasil. Protocolo de uso do Guia Alimentar para a População Brasileira. Volume 2 - Orientação alimentar de pessoas adultas com obesidade [Internet]. Brasília; 2022 [cited 2025 May 13]. Link
67. Brasil. Protocolos de uso do Guia Alimentar para a População Brasileira. Volume 1 - Orientação alimentar de pessoas adultas com obesidade, hipertensão arterial e diabetes mellitus: bases teóricas e metodológicas [Internet]. Brasília; 2022 [cited 2025 May 13]. Link
68. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes Care. 2003 Jan 1;26(suppl_1):s51–61. Link · Registro no PubMed
69. Khan TA, Lee JJ, Ayoub-Charette S, Noronha JC, McGlynn N, Chiavaroli L, et al. WHO guideline on the use of non-sugar sweeteners: a need for reconsideration. Eur J Clin Nutr. 2023 Nov 18;77(11):1009–13. Link · Registro no PubMed
70. Brasil. Manual - Como organizar o cuidado de pessoas com doenças crônicas na APS no contexto da pandemia. Brasília; 2020. Link
71. Oba‐Yamamoto C, Takeuchi J, Nakamura A, Takikawa R, Ozaki A, Nomoto H, et al. Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia. J Diabetes Investig. 2021 Apr 7;12(4):651–7. Link · Resumo no PubMed
72. Brasil. Alimentação Cardioprotetora: manual de orientações para profissionais de saúde da Atenção Básica. Brasília; 2018. Link
73. Brasil. Guia de Atividade Física para a População Brasileira. Brasília; 2021. Link
74. ADA. American Diabetes Association. Standards of Care in Diabetes - 2023 Abridged for Primary Care Providers. Vol. 41, Clinical Diabetes. 2023 Jan. Link · Registro no PubMed
75. Tobacconomics. The Tobacco Atlas. Atlanta: American Cancer Society and Vital Strategies [Internet]. The Tobacco Atlas. 2018 [cited 2025 May 14]. Link
76. Brasil. Cadernos de Atenção Básica - Estratégias para o cuidado da pessoa com doença crônica: o cuidado da pessoa tabagista [Internet]. Brasília; 2015 [cited 2025 May 14]. Link
77. Brasil. Protocolo Clínico e Diretrizes Terapêuticas do Tabagismo [Internet]. Brasília; 2020 [cited 2025 May 14]. Link
78. US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. [Internet]. Atlanta, GA, US. ; 2014 [cited 2025 Jun 3]. Link · Resumo no PubMed
79. Brasil. Linhas de cuidado - Tabagismo. [Internet]. Brasília; 2021 [cited 2025 May 14]. Link
80. Rodrigues GMB, Malerbi FEK, Pecoli PFG, Forti AC e, Bertoluci M. Aspectos psicossociais do diabetes tipos 1 e 2. In: Diretriz Oficial da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2022. Link
81. SUS-BH. Guia de Atuação do Farmacêutico no Cuidado à Pessoa que Vive com Diabetes [Internet]. Belo Horizonte.; 2023 [cited 2025 May 14]. Link
82. Brasil. Estratégias para o cuidado da pessoa com doença crônica [Internet]. Brasília; 2014 [cited 2025 May 14]. Link
83. Brasil. Guia Rápido Autocuidado em Saúde: Literacia para a saúde das pessoas com Diabetes Mellitus tipo 2 [Internet]. Brasília; 2022 [cited 2025 May 14]. Link
84. Jones A, Vallis M, Pouwer F. If it does not significantly change HbA1c levels why should we waste time on it? A plea for the prioritization of psychological well‐being in people with diabetes. Diabetic Medicine. 2015 Feb 10;32(2):155–63. Link · Resumo no PubMed
85. Skinner TC, Carey ME, Cradock S, Dallosso HM, Daly H, Davies MJ, et al. ‘Educator talk’ and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial. Diabetic Medicine. 2008 Sep 29;25(9):1117–20. Link · Resumo no PubMed
86. Brenk-Franz K, Strauß B, Tiesler F, Fleischhauer C, Schneider N, Gensichen J. Patient- provider relationship as mediator between adult attachment and self-management in primary care patients with multiple chronic conditions. J Psychosom Res. 2017 Jun;97:131–5. Link · Resumo no PubMed
87. Parker MM, Fernández A, Moffet HH, Grant RW, Torreblanca A, Karter AJ. Association of Patient-Physician Language Concordance and Glycemic Control for Limited–English Proficiency Latinos With Type 2 Diabetes. JAMA Intern Med. 2017 Mar 1;177(3):380. Link · Resumo no PubMed
88. Hojat M, Louis DZ, Markham FW, Wender R, Rabinowitz C, Gonnella JS. Physiciansʼ Empathy and Clinical Outcomes for Diabetic Patients. Academic Medicine. 2011 Mar;86(3):359–64. Link · Resumo no PubMed
89. Williams JS, Walker RJ, Smalls BL, Hill R, Egede LE. Patient-Centered Care, Glycemic Control, Diabetes Self-Care, and Quality of Life in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2016 Oct;18(10):644–9. Link · Resumo no PubMed
90. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998 Sep;352(9131):837–53. Link · Resumo no PubMed
91. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care [Internet]. 2022 Sep 28;45(11):2753–86. Link · Resumo no PubMed
92. Lyra R, Albuquerque L, Cavalcanti S, Tambascia M, Valente F, Bertoluci M. Tratamento farmacológico da hiperglicemia no DM2. Diretriz Oficial da Sociedade Brasileira de Diabetes. 2022; Link
93. ADA. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022 -Committee, American Diabetes Association Professional Practice. Diabetes Care [Internet]. 2021 Dec 16;45(Supplement_1):S125–43. Link · Resumo no PubMed
94. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023. Diabetes Care [Internet]. 2022 Dec 12;46(Supplement_1):S140–57. Link · Resumo no PubMed
95. UKPDS. Group, U K Prospective Diabetes Study (UKPDS)- Effect of intensive blood- glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998;352(9131):854–65. Link · Resumo no PubMed
96. Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol [Internet]. 2023;19(8):460–76. Link · Resumo no PubMed
97. Moraes EM. A arte da (des) prescrição no idoso: a dualidade terapêutica, 1oed. Belo Horizonte Editora Folium. 2018;266–305. Link
98. Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646–53. Link · Resumo no PubMed
99. de Moraes EN, Reis AMM, de Moraes FL. Manual de terapêutica segura no Idoso. Belo Horizonte Folium. 2019; Link
100. Lyra R, Albuquerque L, Cavalcanti S, Tambascia M, Silva Júnior WS, Bertoluci M. Manejo da terapia antidiabética no DM2. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
101. ElSayed NA, McCoy RG, Aleppo G, Bajaj M, Balapattabi K, Beverly EA, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S181–206. Link · Resumo no PubMed
102. Brasil. Ministério da Saúde. Formulário terapêutico nacional 2010: Rename 2010. 2010; Link
103. Tessier D, Dawson K, Tétrault JP, Bravo G, Meneilly GS. Glibenclamide vs Gliclazide in Type 2 Diabetes of the Elderly. Diabetic Medicine [Internet]. 1994 Dec 1;11(10):974–80. Link · Resumo no PubMed
104. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7). Link · Resumo no PubMed
105. Xu B, Li S, Kang B, Zhou J. The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management. Cardiovasc Diabetol [Internet]. 2022;21(1):83. Link · Resumo no PubMed
106. Brasil. Ministério da Saúde. Diretrizes Clínicas para o Cuidado ao paciente com Doença Renal Crônica – DRC. Link
107. Brasil. Ministério da Saúde. Diretrizes Brasileiras para Diagnóstico e Tratamento da Insuficiência Cardíaca com Fração de Ejeção Reduzida. Link
108. Brasil. Ministério da Saúde. Relatório 524- Empagliflozina e dapagliflozina para o tratamento de diabetes mellitus tipo 2. Link
109. AstraZeneca. Bula Forxiga - Dapagliflozina. Link
110. Bahia L, Almeida-Pititto B de, Bertoluci M. Tratamento do DM2 no SUS. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
111. Lamounier RN, Geloneze B, Leite SO, Montenegro R, Zajdenverg L, Fernandes M, et al. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil. Diabetol Metab Syndr. 2018 Dec 21;10(1):83. Link · Resumo no PubMed
112. LaSalle JR, Berria Rachele. Insulin Therapy in Type 2 Diabetes Mellitus: A Practical Approach for Primary Care Physicians and Other Health Care Professionals. Journal of Osteopathic Medicine. 2013;113(2):152–62. Link · Resumo no PubMed
113. Home PD, Bolli GB, Mathieu C, Deerochanawong C, Landgraf W, Candelas C, et al. Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetes. Diabetes Obes Metab. 2015 Jan 12;17(1):15–22. Link · Resumo no PubMed
114. Stewart-Lynch A, Meyers R, Sidig D, McConville S oh, Heiple L. Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice. Clinical Diabetes. 2024 Apr 1;42(2):266–73. Link · Resumo no PubMed
115. Mehta R, Goldenberg R, Katselnik D, Kuritzky L. Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care. Ann Med. 2021 Jan 24;53(1):999–1010. Link · Resumo no PubMed
116. Dehghani M, Sadeghi M, Barzkar F, Maghsoomi Z, Janani L, Motevalian SA, et al. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials. Front Endocrinol (Lausanne). 2024 Mar 21;15. Link · Resumo no PubMed
117. Misra-Hebert AD, Pantalone KM, Ji X, Milinovich A, Dey T, Chagin KM, et al. Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015. Diabetes Care. 2018 Jun 1;41(6):1164–71. Link · Resumo no PubMed
118. Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ. Insulin Glargine. Drugs. 2003;63(16):1743–78. Link · Resumo no PubMed
119. Owens DR. Stepwise intensification of insulin therapy in Type 2 diabetes management— exploring the concept of the basal‐plus approach in clinical practice. Diabetic Medicine. 2013 Mar 20;30(3):276–88. Link · Resumo no PubMed
120. Diabetes Coalition of California. Type 2 diabetes adult outpatient insulin guidelines. [Internet]. California; 2010 [cited 2025 Jun 8]. Link
121. Wojciechowski P, Niemczyk-Szechowska P, Olewińska E, Jaros P, Mierzejewska B, Skarżyńska-Duk J, et al. Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. Pol Arch Intern Med. 2015 Jan 30;125(3):141–51. Link · Resumo no PubMed
122. Silver B, Ramaiya K, Andrew SB, Fredrick O, Bajaj S, Kalra S, et al. EADSG Guidelines: Insulin Therapy in Diabetes. Diabetes Therapy. 2018 Apr 5;9(2):449–92. Link · Resumo no PubMed
123. Brasil. Relatório de recomendação 949 - Insulinas análogas de ação rápida para tratamento do diabetes mellitus tipo 2 [Internet]. Brasília; 2024 [cited 2025 Sep 1]. Link
124. Paluchamy T. Hypoglycemia: Essential Clinical Guidelines. In: Szablewski L, editor. Blood Glucose Levels . Londres: IntechOpen; 2019. Link
125. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 6. Glycemic Targets: Standards of Care in Diabetes - 2023. Diabetes Care. 2023 Jan 1;46(Supplement_1):S97–110. Link · Resumo no PubMed
126. Cryer PE. Iatrogenic Hypoglycemia as a Cause of Hypoglycemia-Associated Autonomic Failure in IDDM: A Vicious Cycle. Diabetes. 1992 Mar 1;41(3):255–60. Link · Resumo no PubMed
127. The International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. Diabetologia. 2017 Jan 21;60(1):3–6. Link · Registro no PubMed
128. Brasil. Protocolo Clínico e Diretrizes Terapêuticas – Retinopatia Diabética [Internet]. Brasília; 2021 [cited 2025 May 14]. Link
129. Colhoun HM, Lee ET, Bennett PH, Lu M, Keen H, Wang SL, et al. Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes. Diabetologia. 2001 Sep;44(S2):S46–53. Link · Resumo no PubMed
130. Nerbass FB, Lima H do N, Moura-Neto JA, Lugon JR, Sesso R. Censo Brasileiro de Diálise 2022. Brazilian Journal of Nephrology. 2024 Jun;46(2). Link · Resumo no PubMed
131. Wu AYT, Kong NCT, de Leon FA, Pan CY, Tai TY, Yeung VTF, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia. 2005 Jan 23;48(1):17–26. Link · Resumo no PubMed
132. Sá JR, Canani LH, Rangel ÉB, Bauer AC, Escott GM, Zelmanovitz T, et al. Avaliação e tratamento da doença renal do diabetes. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
133. Rolim LC, Thyssen PJ, Flumignan RL, Andrade DC de, Dib SA, Bertoluci M. Diagnóstico e tratamento da neuropatia periférica diabética. In: Diretriz Oficial da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2022. Link
134. Rolim LC, Sá JR de, Chacra AR, Dib SA. Heterogeneidade clínica e coexistência das neuropatias diabéticas: diferenças e semelhanças entre diabetes melito tipos 1 e 2. Arquivos Brasileiros de Endocrinologia & Metabologia. 2009 Oct;53(7):818–24. Link · Resumo no PubMed
135. Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019 Jun 13;5(1):41. Link · Resumo no PubMed
136. Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan 1;40(1):136–54. Link · Registro no PubMed
137. Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016 May 17;44(4):260–77. Link · Resumo no PubMed
138. Willis JR, Doan Q V., Gleeson M, Haskova Z, Ramulu P, Morse L, et al. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States. JAMA Ophthalmol. 2017 Sep 1;135(9):926. Link · Resumo no PubMed
139. Malerbi F, Andrade R, Morales P, Travassos S, Rodacki M, Bertoluci M. Manejo da retinopatia diabética. In: Diretriz Oficial da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2022. Link
140. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003 Jul;136(1):122– 35. Link · Resumo no PubMed
141. Brasil. Protocolo Clínico e Diretrizes Terapêuticas de Sobrepeso e Obesidade em Adultos [Internet]. Brasília; 2020 [cited 2025 May 14]. Link
142. Sacco ICN, Lucovéis M do LS, Thuler SR, Parisi MCR, Bertoluci M. Diagnóstico e prevenção de úlceras no pé diabético. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
143. Brasil. Ministério da Saúde. Manual do pé diabético: estratégias para o cuidado da pessoa com doença crônica [Internet]. Brasília; 2016 [cited 2025 Sep 16]. Link
144. Sacco ICN, Lucovéis M do LS, Thuler SR, Parisi MCR, Bertoluci M. Diagnóstico e prevenção de úlceras no pé diabético. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
145. The International Working Group on the Diabetic Foot (IWGDF). Practical guidelines on the prevention and management of diabetes-related foot disease - Part of the 2023 IWGDF Guidelines on the prevention and management of diabetes-related foot disease [Internet]. 2023 [cited 2025 Sep 16]. Link
146. Duarte Junior EG, Lopes CF, Gaio DRF, Mariúba JV de O, Cerqueira L de O, Manhanelli Filho MAB, et al. Diretrizes da Sociedade Brasileira de Angiologia e de Cirurgia Vascular sobre o pé diabético 2023. J Vasc Bras. 2024;23. Link · Resumo no PubMed
147. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 13. Older Adults: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S266–82. Link · Resumo no PubMed
148. Moura F, Salles JEN, Valente F, Almeida-Pititto B de, Fonseca RMC, Minicucci W, et al. O paciente idoso com diabetes. In: Diretriz da Sociedade Brasileira de Diabetes - Edição 2025. Conectando Pessoas; 2025. Link
149. Lyra R, Albuquerque L, Cavalcanti S, Tambascia M, Silva Júnior WS, Bertoluci M. Manejo da terapia antidiabética no DM2. In: Diretriz da Sociedade Brasileira de Diabetes. Conectando Pessoas; 2024. Link
150. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Briggs Early K, et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care [Internet]. 2025 Jan 1;48(Supplement_1):S86–127. Link · Resumo no PubMed
151. Linsky AM, Motala A, Lawson E, Shekelle P. Deprescribing To Reduce Medication Harms in Older Adults: Rapid Response. 2024 Feb. In: Making Healthcare Safer IV: A Continuous Updating of Patient Safety Harms and Practices [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jul–. PMID: 38349984. Link · Resumo no PubMed
152. ElSayed NA, McCoy RG, Aleppo G, Bajaj M, Balapattabi K, Beverly EA, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025. Diabetes Care [Internet]. 2025 Jan 1;48(Supplement_1):S181–206. Link · Resumo no PubMed
153. ElSayed NA, McCoy RG, Aleppo G, Balapattabi K, Beverly EA, Early B, et al. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025. Diabetes Care [Internet]. 2025 Jan 1;48(Supplement_1):S128–45. Link · Resumo no PubMed
154. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice. 2022 Oct 1;28(10):923–1049. Link · Resumo no PubMed
155. Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043–140. Link · Registro no PubMed
156. Brasil. Protocolos de encaminhamento da atenção básica para a atenção especializada: Endocrinologia e nefrologia [Internet]. Ministério da Saúde, Universidade Federal do Rio Grande do Sul. 2015 [cited 2025 May 14]. Link
157. Brasil. Ministério da Saúde. Relatório no 773- Dapagliflozina para tratamento de pacientes adultos com doença renal crônica em uso de terapia padrão. Link
158. Brasil. Ministério da Saúde. PORTARIA No 11, DE 13 DE MARÇO DE 2017 Torna pública a decisão de incorporar caneta para injeção de insulina humana NPH e insulina humana regular no âmbito do Sistema Único de Saúde - SUS. Link